ECSP12012008A - Nuevos derivados secundarios de 8-hidroxiquinolina-7-carboxamida - Google Patents

Nuevos derivados secundarios de 8-hidroxiquinolina-7-carboxamida

Info

Publication number
ECSP12012008A
ECSP12012008A ECSP12012008A ECSP12012008A EC SP12012008 A ECSP12012008 A EC SP12012008A EC SP12012008 A ECSP12012008 A EC SP12012008A EC SP12012008 A ECSP12012008 A EC SP12012008A
Authority
EC
Ecuador
Prior art keywords
compounds
new secondary
hydroxychinoline
carboxamida
secondary derivatives
Prior art date
Application number
Other languages
English (en)
Inventor
Stefania Gagliardi
Federico Mailland
Michela Legora
Sordo Simone Del
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42025709&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP12012008(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of ECSP12012008A publication Critical patent/ECSP12012008A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

La presente invención provee nuevos derivados secundarios de 8-hidroxiquinolina-7-carboxamida de la fórmula general (I) y las sales farmacéuticamente aceptables de los mismos. Estos compuestos son útiles como agentes anti fúngicos. Específicamente, estos compuestos fueron probados contra Tricophyton Rubrum, Tricophyton Mentagrophytes, Aspergillus Niger y Scopulariopsis Brevicaulis. Estos compuestos también muestran actividad contra especies de Candida como la Candida Albicans y Candida Glabrata.
ECSP12012008 2009-12-29 2012-06-28 Nuevos derivados secundarios de 8-hidroxiquinolina-7-carboxamida ECSP12012008A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09180895A EP2345641A1 (en) 2009-12-29 2009-12-29 New secondary 8-hydroxyquinoline-7-carboxamide derivatives

Publications (1)

Publication Number Publication Date
ECSP12012008A true ECSP12012008A (es) 2012-08-31

Family

ID=42025709

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12012008 ECSP12012008A (es) 2009-12-29 2012-06-28 Nuevos derivados secundarios de 8-hidroxiquinolina-7-carboxamida

Country Status (38)

Country Link
US (1) US8729076B2 (es)
EP (2) EP2345641A1 (es)
JP (1) JP5755245B2 (es)
KR (1) KR20120097407A (es)
CN (1) CN102712596B (es)
AU (1) AU2010338269B2 (es)
BR (1) BR112012015732A2 (es)
CA (1) CA2783230A1 (es)
CL (1) CL2012001759A1 (es)
CO (1) CO6561775A2 (es)
CY (1) CY1115060T1 (es)
DK (1) DK2519504T3 (es)
DO (1) DOP2012000185A (es)
EA (1) EA020487B1 (es)
EC (1) ECSP12012008A (es)
ES (1) ES2460626T3 (es)
GE (1) GEP20156269B (es)
GT (1) GT201200214A (es)
HR (1) HRP20140348T1 (es)
IL (1) IL220307A (es)
MA (1) MA33830B1 (es)
ME (1) ME01748B (es)
MX (1) MX2012007746A (es)
MY (1) MY162548A (es)
NI (1) NI201200115A (es)
NZ (1) NZ600782A (es)
PE (1) PE20121804A1 (es)
PH (1) PH12012501325A1 (es)
PL (1) PL2519504T3 (es)
PT (1) PT2519504E (es)
RS (1) RS53303B (es)
SG (1) SG181588A1 (es)
SI (1) SI2519504T1 (es)
SM (1) SMT201400059B (es)
TN (1) TN2012000319A1 (es)
UA (1) UA109422C2 (es)
WO (1) WO2011080266A1 (es)
ZA (1) ZA201204349B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345643A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
CN104805147B (zh) * 2014-01-26 2018-01-05 上海医药工业研究院 一种二噁英类化合物的制备方法、纯化方法及应用
MX2022010804A (es) 2020-03-04 2023-01-16 Amplyx Pharmaceuticals Inc Uso de compuestos en el tratamiento de infecciones fungicas.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326330A (en) 1885-09-15 Harness-support
US326328A (en) 1885-09-15 Broiler
DE540842C (de) 1930-08-06 1931-12-28 Chinosol Fabrik Akt Ges Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure
FR2160718A1 (en) * 1971-11-23 1973-07-06 Roussel Uclaf 7-benzyl aminomethyl-8-hydroxy quinolines - bacteriostats and fungistats
DE3426995A1 (de) 1984-07-21 1986-01-30 Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart Halterung einer scheibe, vorzugsweise einer windschutzscheibe
CN1180995A (zh) 1995-04-08 1998-05-06 巴斯福股份公司 防治有害真菌的方法
AU4172197A (en) * 1996-09-10 1998-04-02 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
EP1326865B1 (en) 2000-10-12 2009-05-06 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
AU1532802A (en) 2000-10-12 2002-04-22 Merck & Co Inc Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
CN1659143A (zh) 2001-03-01 2005-08-24 盐野义制药株式会社 具有hiv整合酶抑制活性的含氮杂芳基化合物
ATE404537T1 (de) 2002-08-13 2008-08-15 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
FR2889192A1 (fr) * 2005-07-27 2007-02-02 Cytomics Systems Sa Composes antifongiques, compositions contenant ces composes et leurs utilisations
EP2079699A1 (en) * 2006-07-25 2009-07-22 Envivo Pharmaceuticals, Inc. Quinoline derivatives
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345643A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof

Also Published As

Publication number Publication date
EP2519504A1 (en) 2012-11-07
US8729076B2 (en) 2014-05-20
MY162548A (en) 2017-06-15
NZ600782A (en) 2013-11-29
PL2519504T3 (pl) 2014-08-29
EA020487B1 (ru) 2014-11-28
EA201270672A1 (ru) 2012-12-28
TN2012000319A1 (en) 2013-12-12
JP2013515757A (ja) 2013-05-09
EP2345641A1 (en) 2011-07-20
ME01748B (me) 2014-09-20
EP2519504B1 (en) 2014-03-19
HK1178525A1 (en) 2013-09-13
UA109422C2 (xx) 2015-08-25
SI2519504T1 (sl) 2014-05-30
MA33830B1 (fr) 2012-12-03
KR20120097407A (ko) 2012-09-03
NI201200115A (es) 2013-04-22
PE20121804A1 (es) 2013-01-17
DK2519504T3 (da) 2014-05-05
HRP20140348T1 (hr) 2014-05-23
CL2012001759A1 (es) 2012-12-07
US20120316167A1 (en) 2012-12-13
CA2783230A1 (en) 2011-07-07
AU2010338269A2 (en) 2012-08-02
ES2460626T3 (es) 2014-05-14
MX2012007746A (es) 2012-08-03
ZA201204349B (en) 2013-08-28
CY1115060T1 (el) 2016-12-14
SMT201400059B (it) 2014-07-07
PH12012501325A1 (en) 2013-01-07
BR112012015732A2 (pt) 2019-09-24
IL220307A (en) 2015-04-30
WO2011080266A1 (en) 2011-07-07
AU2010338269A1 (en) 2012-07-19
PT2519504E (pt) 2014-04-14
JP5755245B2 (ja) 2015-07-29
CN102712596B (zh) 2014-04-09
CO6561775A2 (es) 2012-11-15
DOP2012000185A (es) 2013-01-15
GT201200214A (es) 2013-09-04
GEP20156269B (en) 2015-04-14
RS53303B (sr) 2014-08-29
IL220307A0 (en) 2012-08-30
SG181588A1 (en) 2012-07-30
CN102712596A (zh) 2012-10-03
AU2010338269B2 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
NI201200114A (es) Nuevos derivados terciarios de 8 - hidroxiquinolina - 7 - carboxamida y usos de los mismos
GT201200215A (es) Derivados secundarios de 8-hidroxiquinolina-7-carboxamida útiles como agentes anti fúngicos
MX2019010602A (es) Inhibidores de cdk.
CO7180199A2 (es) Imidazotriazincarbonitrilos útiles como inhibidores de cinasa
HN2012001744A (es) Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6
CR20150279A (es) Lactamas fusionadas de arilo y heteroarilo
MA35357B1 (fr) Composes de type anilines
ECSP12011878A (es) Derivados de sulfonamida heterocíclicos útiles como inhibidores de mek
EA201500628A1 (ru) Индолкарбоксамидные производные в качестве антагонистов p2xрецепторов
UY32747A (es) 2-carboxamida-cicloamino-ureas sustituidas
UY33907A (es) Derivados de pirazol microbicidas
UY32748A (es) 2-carboxamida-cicloamino-ureas
DOP2012000185A (es) Nuevos derivados secundarios de 8-hidroxiquinolina-7-carboxamida
TH127237A (th) อนุพันธ์เซคันดารี่ 8-ไฮดรอกซิควิโนลีน-7-คาร์บอกซาไมด์สำหรับการใช้เป็นสารต้านเชื้อรา
TH135147A (th) อนุพันธ์เซคันดารี่ 8-ไฮดรอกซิควิโนลีน-7-คาร์บอกซาไมด์ชนิดใหม่
DOP2009000087A (es) Derivados de 2-[1-fenil-5-hidroxi-4alfa-metil-hexahidrococlopenta[f]indazol-5-il]etil fenilo como ligandos del receptor glucocorticoide